Chemed Co. (NYSE:CHE – Get Free Report) CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the transaction, the chief executive officer now directly owns 101,735 shares in the company, valued at $58,270,755.95. The trade was a 1.93 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link.
Chemed Stock Performance
Chemed stock opened at $571.29 on Thursday. Chemed Co. has a 1 year low of $523.33 and a 1 year high of $654.62. The firm has a 50 day moving average price of $578.86 and a 200 day moving average price of $564.98. The company has a market cap of $8.60 billion, a price-to-earnings ratio of 28.87, a PEG ratio of 2.43 and a beta of 0.46.
Chemed (NYSE:CHE – Get Free Report) last announced its quarterly earnings data on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.76 by ($0.12). The company had revenue of $606.18 million for the quarter, compared to analysts’ expectations of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The firm’s quarterly revenue was up 7.4% on a year-over-year basis. During the same period in the prior year, the firm earned $5.32 earnings per share. Sell-side analysts predict that Chemed Co. will post 21.43 EPS for the current year.
Chemed Announces Dividend
Hedge Funds Weigh In On Chemed
Hedge funds and other institutional investors have recently modified their holdings of the company. SG Americas Securities LLC lifted its position in Chemed by 422.9% during the second quarter. SG Americas Securities LLC now owns 7,551 shares of the company’s stock valued at $4,097,000 after buying an additional 6,107 shares in the last quarter. Harbor Capital Advisors Inc. lifted its holdings in shares of Chemed by 292.7% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 1,241 shares of the company’s stock valued at $673,000 after acquiring an additional 925 shares in the last quarter. Hsbc Holdings PLC lifted its holdings in shares of Chemed by 110.0% during the 2nd quarter. Hsbc Holdings PLC now owns 10,638 shares of the company’s stock valued at $5,801,000 after acquiring an additional 5,572 shares in the last quarter. Evergreen Capital Management LLC purchased a new stake in Chemed during the 2nd quarter worth $7,812,000. Finally, Quest Partners LLC increased its holdings in Chemed by 634.3% in the 2nd quarter. Quest Partners LLC now owns 1,990 shares of the company’s stock valued at $1,080,000 after purchasing an additional 1,719 shares in the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of research analysts have weighed in on the company. StockNews.com lowered Chemed from a “buy” rating to a “hold” rating in a research note on Friday, November 22nd. Royal Bank of Canada reduced their target price on Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 5th.
View Our Latest Stock Report on Chemed
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
See Also
- Five stocks we like better than Chemed
- The Risks of Owning Bonds
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What is Short Interest? How to Use It
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Election Stocks: How Elections Affect the Stock Market
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.